News
Supporting innovative eye disease research
Newmedica is supporting research into a potential next generation treatment for diabetic retinopathy, reinforcing its commitment as an eye health champion. Working in partnership with charity Sight Research UK, the project is led by Dr Michael O’Hare and his team...
UK Eye Care Data Hub updated with additional eye conditions
The UK Eye Care Data Hub, the most up-to-date and comprehensive model of the UK’s eyecare workforce and eye diseases in one place, has been expanded to almost double the number of eye conditions and update aspects of the sector...
Glaucoma UK Fellow receives international research award
Dr Giovanni Montesano, the Glaucoma UK Pitts Crick Fellow, has been awarded an ARVO Foundation Early Career Clinician-Scientist Research Award in recognition of his outstanding work in vision research. The award celebrates early career clinician-scientists whose research is shaping the...
Opportunity to take part in research for eyecare professionals advising patients about driving
Claire Howard and Lauren Hepworth are running a study looking which looks to eyecare professionals in the UK who advise patients on DVLA/DVA driving vision standards, as part of their role. The aim of this research is to determine eyecare...
At least 70 percent of cataract patients could benefit from toric IOL
More than two-thirds of cataract patients could benefit from toric intraocular lenses (IOL), according to findings presented at 100% Optical. Consultant ophthalmologist Nigel Kirkpatrick set out how astigmatism is a significant issue for cataract surgery patients during a main stage...
Everyday diabetes medicine could treat common cause of blindness
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...
Over one million estimated to have glaucoma in UK
Over one million people are estimated to currently have glaucoma in the UK, a figure projected to reach more than 1.6 million by 2060, according to a study led by Moorfields and UCL researchers. The new figures, published in the...
Codifying ‘care’ and ‘cure’ behaviours of artificial intelligence systems: now out in Nature Medicine
A new publication in Nature Medicine discusses 'Building a code of conduct for AI-driven clinical consultations' The diversity of AI applications in medicine is growing at an accelerating rate, with that trend set to continue as technology develops. This diversity...
Study to slow short-sightedness in young adults
The University of Bradford is spearheading a study into the progression of short-sightedness among young adults, aiming to tackle one of the fastest-growing global eye health challenges. The research on short-sightedness, also known as myopia, among people aged in their...
Introducing the Interest in Ophthalmology Association
We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...
World-first platform for transparent, fair and equitable use of AI in healthcare
Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...
The College of Optometrists presents Research Excellence Awards to pioneering optometry researchers
The College of Optometrists presented its annual Research Excellence Awards to 2025’s winners at its prestigious annual Diploma and Awards Ceremony on 18 November at Central Hall in Westminster, London. The Research Excellence Awards celebrate the outstanding achievements of talented...
